Source: Eur Respir J 2011; 38: 1482-1483
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Zong Z.Y., Peng C.H.. Ralstonia mannitolilytica and COPD: a case report. Eur Respir J 2011; 38: 1482-1483

Member's Comments

No comment yet.

Related content which might interest you: Pseudomonas aeruginosa in patients hospitalised for COPD exacerbation: a prospective study Source: Eur Respir J 2009; 34: 1072-1078 Year: 2009 An unusual empyema case (candida curvata) and succesfull treatment Source: Annual Congress 2007 - Infectious lung and pleural diseases Year: 2007 Tsukamurella species isolation in bronchiectasis and chronic obstructive pulmonary disease patients: A retrospective case series Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease Year: 2018 Myroides odorarus another one from the new emerging pathogens in cystic fibrosis – case report Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis Year: 2020 Unusual microbes in asthma exacerbation: Alcaligenes xylosoxidans and Leishmania Source: Eur Respir J 2009; 33: 1216-1219 Year: 2009 Pseudomonas aeruginosa isolates in bronchiectasis: Wath particulaties and risk factors? Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations Year: 2016 Does a single Pseudomonas aeruginosa isolation predict COPD mortality? Source: Eur Respir J 2014; 44: 794-797 Year: 2014 Influence of biofim on the bronchial microbiome in COPD patients colonized or infected by pseudomonas aeruginosa Source: International Congress 2015 – Advances from translational research in respiratory infections Year: 2015 Achromobacter (A.) xylosoxidans in cystic fibrosis: prevalence and clinical relevance Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle Year: 2005 The detection of free-living H. influenzae in the airways of patients with COPD Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015 A case report: concurrent pulmonary tuberculosis and pneumococcal endocarditis Source: Eur Respir J 2004; 24: Suppl. 48, 421s Year: 2004 The effect of tobramycin nebulised solution in COPD patients with Pseudomonas aeruginosa in sputum (preliminary report) Source: Eur Respir J 2004; 24: Suppl. 48, 409s Year: 2004 Are COPD patients with Nocardia species identification different from those who have also co-morbid bronchiectasis? Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis Year: 2020 Asternia: case report Source: Eur Respir J 2005; 26: Suppl. 49, 66s Year: 2005 Pseudomonas eradication management in COPD: results from a single centre Source: International Congress 2018 – Pharmacological management of COPD Year: 2018 Late Breaking Abstract - Reduction in frequency of pulmonary exacerbations (PE) with inhaled ARD-3150 in non-cystic fibrosis bronchiectasis (NCFB) patients is independent of Pseudomonas aeruginosa (PA) susceptibility at baseline Source: International Congress 2017 – Update on community acquired pneumonia Year: 2017 Kocuria species: an emerging bacterial infection in critical ill patients Source: International Congress 2019 – CCC Respiratory critical care Year: 2019 Bronchiectasis exacerbations by Pseudomonas aeruginosa: differences and similarities Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease Year: 2018 DNA fingerprinting of Pseudomonas aeruginosa (Pa) in cystic fibrosis patients: risk assessment of cross-colonisation in a CF revalidation centre Source: Eur Respir J 2002; 20: Suppl. 38, 208s Year: 2002 Can LCI predict new Pseudomonas aeruginosa colonization among CF patients?> Source: International Congress 2017 – What is the future for paediatric respiratory physiology and sleep? Year: 2017